Vicor Corp (VICR) Q3 2026 Earnings Call Highlights: Record Revenue

Vicor Corp (VICR) reported Q3 2026 earnings with record revenue, but faces capacity constraints until Fab-2 opens in Q2 2027. Royalty revenue, while growing, is volatile and includes non-recurring payments. Legal expenses rose to $16.1 million, impacting profitability. The company did not provide Q4 revenue guidance due to uncertainty around new licensing deals. Vicor is investing in Fab-2 and Fab-3 to address capacity issues and expects robust demand, particularly from AI-related products.

Original reporting
Published Oct 21, 2026, 5:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 5:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vicor Corp (VICR) Q3 2026 Earnings Call Highlights: Record Revenue — source image
Decision brief

The 30-second read

$VICRNeutralMed
01

Why it matters

The disclosed $43M royalty floor and capacity bottlenecks shape short‑term price expectations, with upside limited until Fab‑2 becomes operational.

02

Market read

New royalty guidance and fab capacity updates provide fresh data for traders; the impact is modest and sector‑specific.

03

What to watch

Potential escalation of ITC investigations may increase royalty rates but also introduce legal risk.

Relevance 7/10Novelty 8/10Timing: post‑earnings call today

Background

Vicor Corp (NASDAQ:VICR) held its Q3 2026 earnings call, providing new guidance on royalty revenue and discussing fab capacity issues.

Company-level read

Ticker impact

$VICRNeutralHigh confidence
Context

Vicor disclosed Q4 royalty minimum of $43M and highlighted capacity constraints at Fab-1, affecting near‑term revenue growth.

Expected impact

modest upside pressure from the new royalty baseline, tempered by near‑term capacity constraints

Evidence & confidence

Investors will price in the $43M royalty floor, but will remain cautious until Fab‑2 ramps up in Q2 2027.

Market effects

Highlights ongoing capacity bottlenecks in the power‑management semiconductor niche, signaling potential demand for fab expansions.

Primarily affects U.S. and North‑American semiconductor investors.

Limited to the niche segment; broader market impact is minimal.

Counterpoint

Capacity constraints could delay revenue growth longer than management suggests, weighing on the stock.

Key entities

  • Vicor Corp

    U.S. listed power‑management semiconductor manufacturer.

  • James Schmidt

    Chief Financial Officer of Vicor.

  • Patrizio Vinciarelli

    Chief Executive Officer of Vicor.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.